CVS Health Corp (CVS)
Cash ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 8,196,000 | 13,043,000 | 13,807,000 | 14,618,000 | 12,945,000 | 17,197,000 | 12,116,000 | 8,442,000 | 9,408,000 | 9,826,000 | 7,119,000 | 5,598,000 | 7,854,000 | 9,256,000 | 14,869,000 | 10,081,000 | 5,683,000 | 5,193,000 | 6,063,000 | 5,896,000 |
| Short-term investments | US$ in thousands | 3,259,000 | 3,145,000 | 3,080,000 | 3,102,000 | 2,778,000 | 2,792,000 | 2,877,000 | 2,900,000 | 3,117,000 | 3,015,000 | 3,006,000 | 3,190,000 | 3,000,000 | 2,831,000 | 2,596,000 | 2,632,000 | 2,373,000 | 2,334,000 | 2,462,000 | 2,426,000 |
| Total current liabilities | US$ in thousands | 79,189,000 | 81,553,000 | 79,206,000 | 75,054,000 | 69,421,000 | 72,409,000 | 68,457,000 | 69,780,000 | 67,807,000 | 64,709,000 | 59,311,000 | 60,104,000 | 62,017,000 | 62,044,000 | 63,694,000 | 59,560,000 | 53,303,000 | 52,544,000 | 49,376,000 | 50,631,000 |
| Cash ratio | 0.14 | 0.20 | 0.21 | 0.24 | 0.23 | 0.28 | 0.22 | 0.16 | 0.18 | 0.20 | 0.17 | 0.15 | 0.18 | 0.19 | 0.27 | 0.21 | 0.15 | 0.14 | 0.17 | 0.16 |
December 31, 2023 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($8,196,000K
+ $3,259,000K)
÷ $79,189,000K
= 0.14
The cash ratio of CVS Health Corp has fluctuated over the past eight quarters, ranging from 0.18 to 0.31. The cash ratio measures a company's ability to cover its short-term liabilities with its readily available cash and cash equivalents.
In Q1 2023, the cash ratio was at its lowest point of 0.29, indicating that CVS Health Corp had $0.29 of cash and cash equivalents for every $1 of current liabilities. This suggests that the company may have had a lower level of liquid assets to meet its short-term financial obligations.
On the other hand, in Q3 2022, the cash ratio reached its peak at 0.31, showing an improvement in CVS Health Corp's liquidity position. A higher cash ratio signifies that the company had more cash on hand relative to its short-term liabilities, indicating a stronger ability to cover its immediate financial obligations.
Overall, the trend in CVS Health Corp's cash ratio fluctuates, reflecting variations in the company's cash holdings and short-term obligations over the quarters analyzed. Investors and stakeholders may monitor this ratio for insights into the company's liquidity and ability to manage its short-term financial commitments.
Peer comparison
Dec 31, 2023